Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Amneal Pharmaceuticals Inc

AMRX
8,76
-0,21 (-2,34%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:30:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202502:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202501:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202501:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202501:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202501:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:02EDGAR2Form 144 - Report of proposed sale of securities
05/3/202522:57EDGAR2Form 144 - Report of proposed sale of securities
05/3/202500:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202512:13EDGAR2Form 8-K - Current report
28/2/202512:00BWAmneal Reports Fourth Quarter and Full Year 2024 Financial..
19/2/202514:00BWAmneal Launches Mesalamine and Receives U.S. FDA Approval..
05/2/202522:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202514:30BWAmneal to Report Fourth Quarter and Full Year 2024 Results..
23/1/202523:49EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
23/1/202514:00BWAmneal Receives U.S. FDA Approval for Memantine/Donepezil..
15/1/202512:14EDGAR2Form 8-K - Current report
10/1/202522:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:48EDGAR2Form 144 - Report of proposed sale of securities
04/12/202414:00BWAmneal to Participate at Upcoming Investor Conferences
26/11/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202416:39EDGAR2Form 144 - Report of proposed sale of securities
21/11/202422:05BWAmneal Resubmits DHE Autoinjector New Drug Application and..
21/11/202420:01EDGAR2Form 144 - Report of proposed sale of securities
19/11/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202419:49EDGAR2Form 144 - Report of proposed sale of securities
14/11/202422:11EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:25EDGAR2Form 8-K/A - Current report: [Amend]
08/11/202412:08EDGAR2Form 8-K - Current report
08/11/202412:00BWAmneal Reports Third Quarter 2024 Financial Results
31/10/202423:51EDGAR2Form SC 13D/A - General Statement of Acquisition of..
21/10/202414:00BWAmneal Receives U.S. FDA Approval of New Drug Application..
08/10/202422:05BWAmneal to Report Third Quarter 2024 Results on November 8,..
01/10/202413:10EDGAR2Form 8-K - Current report
01/10/202412:00BWAmneal and Metsera Announce Strategic Collaboration to..
16/8/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202412:14EDGAR2Form 8-K - Current report
20/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202421:13EDGAR2Form 144 - Report of proposed sale of securities
14/5/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202422:15EDGAR2Form SC 13D/A - General statement of acquisition of..
08/5/202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 8,75 Min: 8,61 Max: 8,85
Chiusura: 8,97

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network